![]() |
![]() |
Intest Res > Epub ahead of print |
|
Funding Source
The authors received no financial support for the research, authorship, and/or publication of this article.
Conflict of Interest
Sood A is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Author Contribution
Conceptualization: Midha V, Sood A. Data curation: Singh A, Narang V, Kedia S, Dhoble P, Kahlon BK, Dhaliwal AS, Tripathi A, Kalra S, Bansal N, Banerjee R, Desai D, Dutta U, Ahuja V. Formal analysis: Singh A, Narang V, Bansal N. Investigation: Singh A, Midha V, Sood A. Methodology: Singh A, Midha V, Sood A. Project administration: Midha V, Sood A. Resources: Singh A, Midha V, Narang V, Dhoble P, Jain NP, Desai D, Sood A. Software: Singh A, Kahlon BK, Bansal N. Supervision: Midha V, Sood A. Visualization: Singh A, Kedia S, Mahajan R, Jain NP, Bansal N, Desai D, Ahuja V, Sood A. Writing - original draft: Singh A, Narang V. Writing - review & editing: all authors. Approval of final manuscript: all authors.
Characteristics | Value (n = 48) |
---|---|
Male sex | 27 (56.25) |
Age at diagnosis of IBD (yr) | 33.67 ± 12.16 |
Age at diagnosis of PSC (yr) | 37.27 ± 12.78 |
Follow up (mo) | 66 (27-129) |
Current or former smoker | 3 (6.25) |
PSC diagnosed before IBD | 4 (8.33) |
IBD diagnosed before PSC | 34 (70.83) |
IBD and PSC diagnosed simultaneously | 10 (20.83) |
Interval between diagnosis of IBD and PSC (mo) | 43.25 ± 74.66 |
Type of IBD | |
Ulcerative colitis | 42 (87.5) |
Crohn’s disease | 6 (12.5) |
Disease extent (ulcerative colitis) | |
Proctitis | - |
Left sided colitis | 13 (30.95) |
Pancolitis | 29 (69.05) |
Mayo Clinic score at diagnosis of IBD | 5.26 ± 2.41 |
Endoscopic Mayo Clinic score at diagnosis of IBD | 1.64 ± 0.62 |
Disease classification (Crohn’s disease) | |
Age at diagnosis | |
< 17 yr | - |
17-40 yr | 4 (66.66) |
> 40 yr | 2 (33.33) |
Disease location | |
Ileal | 1 (16.66) |
Colonic | 3 (50.00) |
Ileo-colonic | 2 (33.33) |
Disease behavior | |
Non-stricturing, non-penetrating | 5 (83.33) |
Stricturing | 1 (16.66) |
Penetrating | - |
Perianal disease | Nil |
Harvey Bradshaw Index at diagnosis of IBD | 5.17 ± 1.33 |
Patients with other extraintestinal manifestationsa | 9 (18.75) |
Arthritis | 5 (10.41) |
Ocular | 4 (8.33) |
Gall stones | 1 (2.08) |
Erythema nodosum | 1 (2.08) |
Family history of IBD | 1 (2.08) |
Previous appendectomy | 4 (8.33) |
Previous exposure to anti-tubercular therapy | 7 (14.58) |
Treatment for IBD | |
5-Aminosalicylates | 39 (81.25) |
Thiopurines | 14 (29.16) |
Anti-TNF | 1 (2.08) |
Corticosteroids | 20 (41.66) |
![]() |
![]() |